Bicara Therapeutics Inc.

BCAX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002023658

SEC filings (opens in a new tab)

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Bicara Therapeutics Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of BCAX: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	106	1	114	+9
Shares	51.2M	42.9K	50.2M	−924.2K (−1.8%)
Value	$475.3M	$398.4K	$792.5M	+$317.6M (+66.9%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Bicara Therapeutics Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to BCAX in Q3 2025
Institution	Shares	Value	% of portfolio
T. Rowe Price Investment Management, Inc.	464,727	$7.34M	0.00%
Clearbridge Investments, LLC	324,321	$5.12M	0.00%
Silverarc Capital Management, LLC	250,606	$3.96M	0.57%
Cantor Fitzgerald, L. P.	100,000	$1.58M	0.03%
ExodusPoint Capital Management, LP	53,882	$850.8K	0.01%
Cinctive Capital Management LP	41,849	$660.8K	0.03%
Bleakley Financial Group, LLC	30,478	$481.2K	0.01%
MetLife Investment Management	21,519	$339.8K	0.00%
Tudor Investment Corp Et Al	18,730	$295.7K	0.00%
Algert Global LLC	17,590	$277.7K	0.00%
LPL Financial LLC	14,297	$225.8K	0.00%
Ascent Group, LLC	13,930	$220.0K	0.01%
Brinker Capital Investments, LLC	11,303	$178.5K	0.00%
Quantinno Capital Management LP	10,577	$167.0K	0.00%
Creative Planning	10,044	$158.6K	0.00%
Caitong International Asset Management Co., Ltd	1,190	$18.8K	0.01%
Simplex Trading, LLC	1,008	$15.0K	0.00%
The PNC Financial Services Group, Inc.	319	$5.04K	0.00%
Point72 Europe (London) LLP	292	$4.61K	0.00%
Private Trust Co NA	225	$3.55K	0.00%
Nisa Investment Advisors, LLC	161	$2.54K	0.00%
Global Retirement Partners, LLC	105	$1.66K	0.00%
CoreCap Advisors, LLC	32	$505	0.00%
Farther Finance Advisors, LLC	15	$237	0.00%
SBI Securities Co., Ltd.	1	$16	0.00%

Sold out (16)

Institutions that held Bicara Therapeutics Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of BCAX in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Foresite Capital Management VI LLC	949,260	$8.82M
Artisan Partners Limited Partnership	402,765	$3.74M
Logos Global Management LP	400,000	$3.72M
Readystate Asset Management LP	270,200	$2.51M
Citadel Advisors LLC	221,516	$2.06M
Verition Fund Management LLC	170,962	$1.59M
Cubist Systematic Strategies, LLC	102,525	$952.5K
Skandinaviska Enskilda Banken AB (publ)	99,236	$921.9K
Catalio Capital Management, LP	97,800	$908.6K
Atom Investors LP	55,141	$512.3K
Susquehanna International Group, LLP	43,248	$401.8K
Jane Street Group, LLC	28,604	$265.7K
Walleye Capital LLC	24,308	$225.8K
Squarepoint Ops LLC	13,363	$124.1K
Kessler Investment Group, LLC	200	$1.86K
IFP Advisors, Inc	2	$19

Not filed for Q3 2025 yet (1)

Institutions that held Bicara Therapeutics Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BCAX in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Norges Bank	42,889	$398.4K